• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺癌的热放疗

Thermoradiotherapy of primary breast carcinoma.

作者信息

Hofman P, Knol R G, Lagendijk J J, Schipper J

机构信息

Department of Radiotherapy, University Hospital, Utrecht, The Netherlands.

出版信息

Int J Hyperthermia. 1989 Jan-Feb;5(1):1-11. doi: 10.3109/02656738909140428.

DOI:10.3109/02656738909140428
PMID:2493510
Abstract

Since 1981, 40 patients with advanced breast carcinoma have been treated with megavoltage radiotherapy combined with hyperthermia. The irradiation dose to the primary tumour was 50 Gy/25 fractions, five fractions per week. Hyperthermia (aim: 44 degrees C/30 min) was applied once a week, 30 minutes after the midweek radiation fraction. Tumour response did not correlate with the chance of long-term local control. The likelihood of 3-year local control was 46 per cent and 3-year survival was 52 per cent. The local tumour control rate decreased with increasing T stage and was related to non-uniformity of the temperature distribution in the heated volume. It was concluded that (a) the radiation dose should be increased and (b) the temperature uniformity should be improved.

摘要

自1981年以来,40例晚期乳腺癌患者接受了兆伏级放疗联合热疗。原发肿瘤的照射剂量为50 Gy/25次分割,每周5次分割。热疗(目标:44摄氏度/30分钟)每周进行一次,在周三放疗分割后30分钟进行。肿瘤反应与长期局部控制的可能性无关。3年局部控制率为46%,3年生存率为52%。局部肿瘤控制率随T分期增加而降低,且与加热体积内温度分布不均匀有关。得出的结论是:(a)应增加放射剂量;(b)应提高温度均匀性。

相似文献

1
Thermoradiotherapy of primary breast carcinoma.原发性乳腺癌的热放疗
Int J Hyperthermia. 1989 Jan-Feb;5(1):1-11. doi: 10.3109/02656738909140428.
2
Multiple field hyperthermia combined with radiotherapy in advanced carcinoma of the breast.多野热疗联合放疗治疗晚期乳腺癌
Int J Hyperthermia. 1994 Sep-Oct;10(5):587-603. doi: 10.3109/02656739409022440.
3
Thermoradiotherapy for locally recurrent breast cancer with skin involvement.皮肤受累的局部复发性乳腺癌的热放疗
Int J Hyperthermia. 2001 Jul-Aug;17(4):291-301. doi: 10.1080/02656730110049538.
4
[Clinical results of thermoradiotherapy of locally advanced and recurrent breast cancers--comparison of results with radiotherapy alone].[局部晚期及复发性乳腺癌热放疗的临床结果——与单纯放疗结果的比较]
Nihon Igaku Hoshasen Gakkai Zasshi. 1989 Mar 25;49(3):304-13.
5
Prognostic factors for tumour response and skin damage to combined radiotherapy and hyperthermia in superficial recurrent breast carcinomas.浅表复发性乳腺癌联合放疗与热疗时肿瘤反应及皮肤损伤的预后因素
Int J Hyperthermia. 1995 May-Jun;11(3):337-55. doi: 10.3109/02656739509022470.
6
Assessment of combined thermoradiotherapy in recurrent of advanced carcinoma of the breast.晚期乳腺癌复发患者联合热放疗的评估
Adv Exp Med Biol. 1990;267:521-3. doi: 10.1007/978-1-4684-5766-7_56.
7
Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer--comparison of results with radiotherapy alone.局部晚期和/或复发性乳腺癌热放疗的临床结果——与单纯放疗结果的比较
Int J Hyperthermia. 1990 May-Jun;6(3):487-97. doi: 10.3109/02656739009140945.
8
Arterial rupture after microwave-induced hyperthermia and radiotherapy. With reference to two patients treated for recurrence in previously operated and irradiated areas.微波诱导热疗和放疗后动脉破裂。参考两名在先前手术和放疗区域复发接受治疗的患者。
Int J Hyperthermia. 1990 May-Jun;6(3):499-509. doi: 10.3109/02656739009140946.
9
[Clinical assessment of thermoradiotherapy of breast cancer and cancer of the urinary bladder].
Gan No Rinsho. 1990 Oct;36(13):2267-71.
10
Outpatient interstitial thermoradiotherapy.门诊间质热放疗。
Cancer. 1996 Jun 1;77(11):2363-70. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2363::AID-CNCR27>3.0.CO;2-U.

引用本文的文献

1
Hyperthermia for locally advanced breast cancer.局部晚期乳腺癌的热疗。
Int J Hyperthermia. 2010;26(7):618-24. doi: 10.3109/02656736.2010.501051.
2
'Patchwork' fields in thermoradiotherapy for extensive chest wall recurrences of breast carcinoma.乳腺癌广泛胸壁复发热放疗中的“拼凑”野
Breast Cancer Res Treat. 1993 Sep;27(3):263-70. doi: 10.1007/BF00665696.